Jacobio Pharmaceuticals Group Co., Ltd. Financial Overview
Jacobio Pharmaceuticals Group Co., Ltd.'s market cap is currently HK$7.17B. The company's EPS TTM is HK$-0.0874537728; its P/E ratio is -123.31; Jacobio Pharmaceuticals Group Co., Ltd. is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is HK$-0.12. See an overview of income statement, balance sheet, and cash flow financials.
